British Business Investments Ltd, a commercial subsidiary of the British Business Bank, has made a new £30m subscription in specialist lender Shawbrook Group plc’s £75 million Tier 2 note issuance. The investment follows an original £30m subscription to Shawbrook Bank’s previous Tier 2 note issuance in 2015, which has now been repaid.

BGV's Paul Miller explains why now, more than ever, the case for investing in Tech for Good is so compelling.

Global technology investor, Amadeus Capital Partners, today announces a major expansion of its investment team. Edward Kliphuis and Kai Schmitz have joined as Partners and Ana Bernardo-Gancedo as a Healthcare Analyst.

The British Business Bank, the UK’s national economic development bank, has published its 2020 Annual Report and Accounts for this, its sixth year of operation.

Crista Galli Ventures, a new early-stage healthtech fund that offers patient capital and deep healthcare expertise, has launched this week.  Crista Galli Ventures partners with early-stage founders at Seed and Series A to build world-leading companies, and has tailored its strategy to the needs of ambitious healthtech entrepreneurs, and the unique industry in which they operate.

Finance Durham Fund has invested £750,000 in Growth Capital Ventures. The investment through Finance Durham, managed by Maven Capital Partners, will support GCV’s growth plans as it seeks to further develop its three main business units G-Labs, G-Ventures and Quva, as well as move premises to larger offices within County Durham.   

Pitchbook Data recently published their Q2 2020 Global League Tables and named SFC Capital (formerly Startup Funding Club) the Most Active Angel & Seed investor in Europe. SFC Capital is only behind SOSV and 500 Startups on the Global list of Seed investors for this period.

UK-based start-up Skin Analytics has raised £4 million in Series A funding. The funding round was led by Hoxton Ventures with participation from Nesta and Mustard Seed Ventures.

British Business Investments Ltd, a commercial subsidiary of the British Business Bank, has made its fourth commitment through its £500m Managed Funds Programme.

The cornerstone commitment of up to €75m is being made to manager Isomer Capital's second fund, Isomer Capital II. The fund will be targeted at early stage venture capital managers across Europe, that invest primarily into early stage tech companies. Isomer II will also pursue a co-investment strategy, investing alongside its fund managers, with additional capital made available for the most promising, high-growth companies from the underlying portfolio.

Following a period of sustained growth since launching Fund II in March 2019, Playfair Capital is bolstering its team in London with three new hires.

BGF, the UK’s most active growth capital investor, has invested £3 million into 365 Response, a Wakefield-based technology business which provides mission critical transport management and eProcurement software to NHS and local government organisations, as well as private transport providers supporting the delivery of community based mobility and wellbeing services.  

ClinSpec Diagnostics, a university spin-out which has developed a way to detect cancer at an early stage using a simple blood test, has completed a £2.4m funding round led by Mercia’s EIS funds.